Nauvent
Brand Name: Nauvent
Generic Name: Ondansetron (as hydrochloride)
Active
Registration Number
DRP-4089-03
Dosage Form
Solution for Injection (IM/IV)
Issuance Date
January 31, 2023
Expiry Date
November 8, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength2 mg/mL (4 mg/2 mL)
Packaging2mL USP Type I Amber Glass Ampoule (Box of 5's)
Classification
C
Classification
Prescription Drug (Rx)
A
Application
CLIDP Conversion
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Ondansetron (as hydrochloride)Active
Monograph: Ondansetron